|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Teleflex Incorporated |
TFX |
879369106 |
514 |
$83,052.12 |
2.52% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
978 |
$78,865.92 |
2.39% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
754 |
$76,794.90 |
2.33% |
| Steris Plc |
STE |
G8473T100 |
300 |
$76,728.00 |
2.33% |
| LivaNova Plc |
LIVN |
G5509L101 |
841 |
$76,303.93 |
2.32% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,636 |
$75,603.87 |
2.30% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
595 |
$74,664.96 |
2.27% |
| Becton, Dickinson and Company |
BDX |
075887109 |
350 |
$74,473.00 |
2.26% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,006 |
$73,573.98 |
2.23% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,534 |
$73,551.08 |
2.23% |
| Medtronic Plc |
MDT |
G5960L103 |
727 |
$72,656.38 |
2.21% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
721 |
$72,893.10 |
2.21% |
| Stryker Corporation |
SYK |
863667101 |
232 |
$71,920.00 |
2.18% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
984 |
$71,350.47 |
2.17% |
| Cochlear Limited |
COH.AU |
Q25953102 |
718 |
$70,793.01 |
2.15% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$70,854.63 |
2.15% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,763 |
$70,586.51 |
2.14% |
| Align Technology, Inc. |
ALGN |
016255101 |
450 |
$69,826.50 |
2.12% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,182 |
$69,596.16 |
2.11% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
202 |
$69,331.69 |
2.10% |
| BioMerieux |
BIM.FP |
F1149Y232 |
690 |
$68,993.53 |
2.09% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
176 |
$68,692.80 |
2.09% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,467 |
$68,645.35 |
2.08% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$68,342.08 |
2.07% |
| Baxter International Inc. |
BAX |
071813109 |
2,640 |
$67,029.60 |
2.04% |
| Abbott Laboratories |
ABT |
002824100 |
645 |
$66,435.00 |
2.02% |
| ResMed Inc. |
RMD |
761152107 |
279 |
$65,740.77 |
2.00% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
98 |
$65,614.92 |
1.99% |
| Waters Corporation |
WAT |
941848103 |
148 |
$65,186.60 |
1.98% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
270 |
$64,493.49 |
1.96% |
| Agilent Technologies, Inc. |
A |
00846U101 |
377 |
$64,233.26 |
1.95% |
| Danaher Corporation |
DHR |
235851102 |
292 |
$64,345.12 |
1.95% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,404 |
$64,313.53 |
1.95% |
| Penumbra, Inc. |
PEN |
70975L107 |
201 |
$64,143.12 |
1.95% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,258 |
$63,408.08 |
1.93% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
176 |
$63,166.40 |
1.92% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,504 |
$63,137.92 |
1.92% |
| Insulet Corporation |
PODD |
45784P101 |
475 |
$63,255.75 |
1.92% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
737 |
$62,158.58 |
1.89% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,771 |
$61,290.32 |
1.86% |
| DexCom, Inc. |
DXCM |
252131107 |
764 |
$60,600.48 |
1.84% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
152 |
$60,655.60 |
1.84% |
| Revvity, Inc. |
RVTY |
714046109 |
417 |
$60,556.74 |
1.84% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
797 |
$58,667.17 |
1.78% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,140 |
$58,417.37 |
1.77% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
861 |
$57,592.29 |
1.75% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$55,145.46 |
1.67% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$53,970.82 |
1.64% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,587.48 |
1.35% |
| US Dollar |
$USD |
|
5,990 |
$5,990.30 |
0.18% |
| Japanese Yen |
$JPY |
|
237,600 |
$1,498.30 |
0.05% |
| Euro |
$EUR |
|
0 |
$0.05 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.14 |
0.00% |
| Swiss Franc |
$CHF |
|
0 |
$0.00 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|